Bernard Davitian joined Omega Funds in 2020 as a Partner. He has extensive pharma and biotech experience, serving on boards and previously at Sanofi Ventures.
At firms with a similar stage, sector and check size.




One email when Bernard's firm raises a fund, adds a partner or shows new activity.

Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.
Send your deckBernard Davitian joined Omega Funds in 2020 as a Partner. He has extensive pharma and biotech experience, serving on boards and previously at Sanofi Ventures.
Bernard Davitian invests through Omega Funds, which writes checks of $10M to $30M+ at seed, series a, series b.
Email [email protected], the firm's inbox for founders, and name Bernard in the subject. A warm intro from a founder Omega Funds backed works better.
Neurotech Pharmaceuticals; CEO, CFO and other leadership roles at Fovea Pharmaceuticals; Vice President, Deputy Global Head, Business Development at Sanofi; SVP and Managing Director at Sanofi Ventures; leadership role at Institut Merieux; leadership role at Transgene; leadership role at Neurotech Pharmaceuticals.
Last updated 2026-10-15. Is this you? Ask for a correction.